摘要
目的分析依达拉奉联合低分子肝素钙在进展型脑梗死治疗中的应用价值。方法选取我院收治的70例进展型脑梗死患者临床资料进行回顾分析。结果 两组患者临床疗效比较,有统计学意义(P<0.05)。结论 依达拉奉联合低分子肝素钙在进展型脑梗死治疗中应用价值较高。
Objective To analyze the adr in combination of low molecular heparin calcium application value in the treatment of progressive cerebral infarction. Methods Choose 70 cases of our hospital from progressive cerebral infarction patients were retrospective analysis of clinical data. Results The clinical efficacy of two groups of patients, with statistical significance （P〈0.05）. Conclusion In accordance with edaravone in combination of low molecular heparin calcium application value in the treatment of progressive cerebral infarction is higher, is worth promoting.
出处
《中国继续医学教育》
2014年第8期155-156,共2页
China Continuing Medical Education
关键词
依达拉奉
低分子肝素钙
脑梗死
Edaravone Low molecular heparin Cerebral infarction
